These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 37501187)
41. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors. Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160 [TBL] [Abstract][Full Text] [Related]
42. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma. Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232 [TBL] [Abstract][Full Text] [Related]
43. Differential Expression of the Hu J; Xu J; Feng X; Li Y; Hua F; Xu G Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699 [TBL] [Abstract][Full Text] [Related]
44. A Pan-Cancer Analysis of the Oncogenic Role of Yang D; Li H; Chen Y; Li C; Ren W; Huang Y Front Genet; 2022; 13():906174. PubMed ID: 35910232 [No Abstract] [Full Text] [Related]
45. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171 [TBL] [Abstract][Full Text] [Related]
46. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis. Wang Y; Gong H; Cao Y Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547 [TBL] [Abstract][Full Text] [Related]
47. SPP1 could be an immunological and prognostic biomarker: From pan-cancer comprehensive analysis to osteosarcoma validation. Zhang Z; Liu B; Lin Z; Mei L; Chen R; Li Z FASEB J; 2024 Jul; 38(14):e23783. PubMed ID: 39037571 [TBL] [Abstract][Full Text] [Related]
48. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299 [TBL] [Abstract][Full Text] [Related]
49. Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1. Hao J; He AY; Zhao X; Chen XQ; Liu QL; Sun N; Zhang RQ; Li PP Cancer Control; 2023; 30():10732748231170485. PubMed ID: 37072373 [No Abstract] [Full Text] [Related]
50. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
51. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation. Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349 [TBL] [Abstract][Full Text] [Related]
52. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
53. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression. Wang B; Chen L; Li Q; Zhou J; Jin W Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553 [TBL] [Abstract][Full Text] [Related]
54. Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity. Chen F; Fan Y; Liu X; Zhang J; Shang Y; Zhang B; Liu B; Hou J; Cao P; Tan K Front Mol Biosci; 2021; 8():789703. PubMed ID: 35087869 [TBL] [Abstract][Full Text] [Related]
55. Systematic Analyses of the Role of the Reader Protein of Shao XY; Dong J; Zhang H; Wu YS; Zheng L Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502 [TBL] [Abstract][Full Text] [Related]
56. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863 [TBL] [Abstract][Full Text] [Related]
57. Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma. Liu J; Li W; Wu L Front Pharmacol; 2022; 13():950156. PubMed ID: 36046831 [TBL] [Abstract][Full Text] [Related]
58. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
59. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses. Wang J; Gilani SF; Noor N; Ahmed MR; Munazir M; Zubair A; Sultan R; Abdel-Maksoud MA; Saleh IA; Zomot N; Kodous AS; Ibrahim SS; El-Tayeb MA; Aufy M; Zaky MY; Hassan SS; Hameed Y Am J Transl Res; 2024; 16(3):738-754. PubMed ID: 38586115 [TBL] [Abstract][Full Text] [Related]
60. [A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment]. Yao Y; Liu J; Zhou X; Liu Z; Qiu S; He Y; Zhou X Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):70-82. PubMed ID: 38293978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]